John M Stuart Selected Research

John M Stuart Research Topics

Disease

28	Arthritis (Polyarthritis) 08/2022 - 01/2002
17	Experimental Arthritis 12/2021 - 01/2002
11	Rheumatoid Arthritis 08/2022 - 12/2002
6	Inflammation (Inflammations) 12/2021 - 01/2007
3	Autoimmune Diseases (Autoimmune Disease) 12/2021 - 01/2006
1	Osteoarthritis 04/2014

Drug/Important Bio-Agent (IBA)

14	Collagen Type II (Type II Collagen)IBA 01/2019 - 01/2002
12	Peptides (Polypeptides)IBA 12/2016 - 12/2002
7	CytokinesIBA 12/2021 - 01/2002
7	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2016 - 12/2005
6	Proteins (Proteins, Gene)FDA Link 01/2016 - 12/2005
5	HLA-DR1 Antigen (HLA DR1 Antigen)IBA 08/2022 - 12/2002
5	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2016 - 12/2005
5	AntigensIBA 01/2014 - 04/2004
4	CollagenIBA 08/2022 - 03/2004
4	AntibodiesIBA 12/2021 - 06/2004
3	LigandsIBA 12/2016 - 01/2007
2	Immunoglobulin G (IgG)IBA 01/2019 - 10/2017
2	Interleukin-4 (Interleukin 4)IBA 12/2016 - 09/2011
2	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 01/2006 - 04/2004
2	HLA-DRB1 Chains (HLA DRB1)IBA 12/2005 - 12/2002
2	HLA-DR Antigens (HLA-DR)IBA 06/2004 - 04/2004
1	serum P-component (CIt)IBA 08/2022
1	Extracellular Matrix ProteinsIBA 08/2022
1	Phosphates (Orthophosphate)IBA 08/2022
1	Collagen Type I (Type I Collagen)IBA 08/2022
1	hydroxide ionIBA 12/2021
1	Calcitriol (Calcijex)FDA LinkGeneric 12/2021
1	20-hydroxyvitamin D3IBA 12/2021
1	Vitamin D FDA LinkGeneric 12/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	protein kinase DIBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 12/2016
1	Syk KinaseIBA 12/2016
1	allophycocyaninIBA 05/2016
1	Matrix Metalloproteinases (MMPs)IBA 05/2016
1	Interleukin-1 (Interleukin 1)IBA 02/2013
1	Fc Receptors (Fc Receptor)IBA 09/2011
1	AutoantigensIBA 01/2007
1	Immunoglobulins (Immunoglobulin)IBA 11/2004
1	Cyanogen BromideIBA 11/2004
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 11/2004
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 06/2004
1	Lysine (L-Lysine)FDA Link 03/2004
1	TolerogenIBA 01/2002

Therapy/Procedure

4	Therapeutics 12/2021 - 01/2010
1	Precision Medicine 04/2014
1	Immunotherapy 01/2007